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Abstract We show here that ergtoxin (ErgTx) is a bona fide,
specific blocker of the human ether-a-go-go-related gene
(HERG) channels. It does not affect the function of either M-
eag or M-elk channels. A chimeric construction containing a
segment of the P-region of M-eag channel inserted into the
HERG channel drastically diminished or completely abolished
the inhibitory effect of ErgTx, whereas chimeras of the P-region
of HERG channel into M-eag channels recovered the inhibitory
effect. From the P-region point mutants of HERG channel
assays, only the mutant N598Q shows about 25% decrement of
the ErgTx inhibitory effect. ErgTx recognizes the P-region of
HERG channels, blocking the channel function with a Kd in the
order of 12 nM. ß 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
Key words: Human ether-a-go-go-related gene channel; K
channel; Ergtoxin; M-elk channel; M-eag channel; Scorpion
toxin
1. Introduction
The human ether-a-go-go-related gene (HERG) is a mem-
ber of the Eag super family of genes encoding potassium
channels with six transmembrane domains, an S4 region and
a highly conserved P-region [1]. Mutations in HERG give rise
to inherited, type 2 long QT syndrome [2], caused by a loss of
the cardiac repolarizing current IKr [3,4]. Currents arising
from expression of HERG or ERG, as the homologs in other
species are known, also play a rolle in spike-frequency adap-
tation in neurons [5] and in human pancreatic L-cells [6].
ERG channels are the target of a group of potent drugs
including anti-arrhythmics, anti-histamines and antibiotics
[7,8] that block K currents causing acquired long QT syn-
drome as a side e¡ect. The discovery of naturally occurring
substances that can speci¢cally and reversibly block or recog-
nize these types of channels is fundamental for the search and
development of new putative drugs to treat some of the dis-
eases and malfunctions associated with HERG channels. For
the voltage-dependent K channels the use of scorpion toxins
[9^11] has been extremely useful to determine the geometry of
the outer vestibule of the pore of the channel, to conduct
studies of double mutants (channel and toxin coding genes)
for correlation of the structure with the function of the li-
gand^receptor complexes [12^18]. Two main kinds of natu-
rally occurring peptides from scorpions and spiders have
been isolated and characterized: (i) the blocker toxin type,
that interacts with the outer vestibule of the pore inhibiting
the channels by physically occluding the K conduction [19],
in a 1:1 stoichiometric relationship, and (ii) the gating modi-
¢er, that interacts with the S3^S4 segments of the channel in a
1:4 stoichiometry relationship and modi¢es the closing and
opening kinetics of the channel [20,21].
We have recently found ergtoxin (ErgTx) [22,23], the ¢rst
scorpion peptide capable of blocking speci¢cally ERG chan-
nels. In this communication we describe the interaction of
ErgTx with three chimeras of HERG and M-eag channels
and six di¡erent point mutants involving the P-region of the
HERG channel.
2. Materials and methods
2.1. Preparation of chimeras and point mutants
The nomenclature for chimeras adopted in this communication was
selected by using the ¢rst letter of each channel (either H, standing for
HERG; or M, standing for M-eag; note the italics, which distinguish
the letters from amino acid residues). Thus, HMH means a chimera
where the upstream sequence of the gene encoding HERG channel
was used, followed by a segment of the M-eag gene (here only se-
quences that encode the pore region of the channel) and the extending
sequence to the end of the C-terminal region of the channel was again
from HERG channels. Conversely, MHM means a construction of a
chimeric gene where the N-terminal is from M-eag, the pore segment
contains HERG gene sequence and the C-terminal is again from M-
eag.
The cDNA for chimera HMH was constructed from two PCR
reactions. The ¢rst ampli¢ed the pore of M-eag; a 5P end tag of
HERG clone was introduced and a BglII site of M-eag 3P end was
eliminated. The second PCR ampli¢ed the ¢rst product, using HERG
channel as template; a BstEII site of HERG clone was introduced.
The PCR product (M-eag pore with 5P end of HERG) and the HERG
clone into pCDNA3 were digested with BstEII and BglII (a BglII site
of pCDNA3 was eliminated). The ¢nal PCR product was then sub-
cloned into the corresponding site of the HERG gene.
The encoded channel was composed of HERG sequences from the
amino-terminus to residue C566, at which point it crossed over to M-
eag residue I396. At M-eag residue K577, the sequence again crossed
back to HERG at residue K638.
Chimeras MHM and M382H were constructed using an in vitro
recombination technique as previously described by Herzberg et al.
[24]. The ¢rst crossover point in the MHM construct occurs between
M-eag residue V449 and HERG residue V611. The second crossover
point occurs after HERG residue L650 to M-eag residue L498. For
M382H, the crossover occurs between M-eag residue 382 and HERG
residue M619.
0014-5793 / 02 / $22.00 ß 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 2 1 8 - 5
*Corresponding author. Fax: (52)-73-172388.
E-mail address: possani@ibt.unam.mx (L.D. Possani).
FEBS 25603 17-12-01
FEBS 25603 FEBS Letters 510 (2002) 45^49
The point mutations of HERG gene were prepared by direct muta-
genesis by two step PCR reactions in which appropriate primers were
used. The correct presence of mutants was veri¢ed by sequencing the
products in an automatic Applied Biosystems machine.
2.2. Toxin puri¢cation
ErgTx was puri¢ed by chromatographic procedures as earlier de-
scribed [23].
2.3. Channel expression in oocytes
Complementary RNAs for injection into oocytes were synthesized
from the T7 promoter of linearized DNA templates at the PvuI site
using the Mmessage Mmachine kit (Ambion, Austin, TX, USA). The
oocytes were prepared following the technique described earlier [24].
In brief, female Xenopus laevis frogs (Nasco) were anesthetized by 15
min exposure to 0.15% of 3-aminobenzoic acid ethyl ester (Sigma).
The oocytes were surgically removed from the ovary, after which the
frog was closed by suturing and placed in water to allow recovery
from the anesthesia. Defolliculation was performed by incubation for
1 h in 1.5 mg/ml collagenase (Sigma Type II) in Ca2-free OR2 oocyte
medium with gentle agitation. Oocytes were stored in ND96 solution
(in nM): 96 NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES bu¡er
adjusted to pH 7.4 with NaOH and supplemented with 10 Wg/ml
gentamicin) at 18‡C. Oocytes were injected with 50 nl of cRNA
(0.3 ng/ml) by using a microdispenser and a micropipette. Injected
oocytes were incubated at 18‡C for 24^48 h in ND96 medium, before
analysis.
2.4. Electrophysiological recordings
Channels were expressed to a level where 0.5^5.0 WA of current was
recorded during a depolarizing step from a holding potential of 380
mV to potentials between 380 and +60 mV, and repolarizing at 3100
mV. Currents were recorded using the two-electrode voltage clamp
method (CA-1B high performance oocyte clamp DAGAN). Electro-
des were ¢lled with 3 M KCl, had a resistance of 0.3^1.0 M6. The
bath solution contained (mM) 95 NaCl, 5 KCl, 1 MgCl2, 0.3 CaCl2,
5 HEPES bu¡er adjusted to pH 7.4 with NaOH. Control records were
taken prior to the addition of toxin. On the addition of toxin the
perfusion medium was stopped to allow homogeneous dispersion of
the toxin. In most experiments toxin was removed from the bath to
demonstrate recovery.
3. Results and discussion
3.1. Speci¢city of ErgTx e¡ect in oocyte expressed channels
ErgTx e¡ects were originally reported on ERG-like currents
in native neural and cardiac tissues and tissue-derived cell
lines shown to express the gene encoding ERG [22]. In the
present study we assessed the speci¢city of the ErgTx inter-
action by comparing its relative e¡ects on heterologously ex-
pressed K-subunits of HERG, M-eag and M-elk channels in
Xenopus oocytes. The aim of this study was to determine
whether ErgTx was speci¢c for ERG and to identify the re-
gion of toxin binding on the channel. Fig. 1 shows the record-
ings of toxin e¡ect (left panel control, right panel after toxin
application) on M-eag channels (Fig. 1A), M-elk channels
(Fig. 1B) and HERG channels (Fig. 1C). The current was
decreased only for the HERG channels. Fig. 1D shows the
current versus voltage pro¢le of the inhibitory e¡ect of ErgTx
in HERG channels. Inhibition was almost fully reversible as
shown in the ¢gure by the circles. A dose^response curve for
the e¡ect of ErgTx (Fig. 1E) shows a Kd value of 11.4 nM.
This ErgTx sensitivity is similar to that observed for ERG-like
currents in native cells and cell lines (16 nM; see [22]). The M-
eag and M-elk channels (Fig. 1A,B, respectively) were not
inhibited, even after application of a toxin concentration in
the range of 200 nM. These experiments were repeated several
times (n = 6) with identical results. Our ¢ndings provide addi-
tional con¢rmation that the previously recorded native cur-
rents [22] arise from channels composed primarily of the ERG
K-subunit. The high sensitivity of HERG for the ErgTx also
suggested that the heterologous expression system, together
with manipulation of the HERG channel structure using re-
combinant DNA techniques, would provide a useful means by
which to identify the binding domain of ErgTx on the HERG
channel.
Fig. 1. E¡ect of ErgTx on three di¡erent K channels. K currents were measured in oocytes expressing: (A) M-eag, (B) M-elk and (C)
HERG channels. Left panels are control recordings, right panels are in the presence of 100 nM ErgTx, from a holding potential of 380 mV to
+60 mV by increments of 10 mV each, whereas the tail currents were elicited by repolarization to 3100 mV. Panel D represents a current ver-
sus voltage trace of the inhibitory e¡ect of ErgTx on HERG channels, in which the squares are control traces, triangles are in the presence of
toxin and circles are the recovery of currents after washing the toxin. Panel E is a dose^response curve for ErgTx on HERG channels. The cal-
culated IC50 was 50 ng/ml (n = 3), using (1+([ErgTx]/IC50)p)31), P6 0.65.
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3.2. Mapping the receptor site for ErgTx binding
We took advantage of the homology between HERG and
M-eag to make chimeras and determine what regions of
HERG uniquely specify ErgTx sensitivity (Fig. 2). Because
previous studies have shown that other scorpion toxins bind
to the pore region of voltage-gated K channels of the Kv
family, we tested the hypothesis that the pore-forming region
serves as the ErgTx binding site in HERG. According to this
hypothesis, chimeric M-eag channels with an HERG pore
should be inhibited by ErgTx. If the binding were in a di¡er-
ent region of HERG, such as the S3^S4 loop serving as the
spider hanatoxin receptor in K channels [20,21], sensitivity
would be determined by the parent channel in regions outside
the pore. Fig. 2 shows the chimeras schematically, with M-eag
sequences in un¢lled boxes and HERG sequences in ¢lled
boxes. We also tested six constructs with point mutations in
the corresponding region, as indicated with asterisks.
As a model, we will refer to sub-domains of the bacterial
channel KcsA pore, which have been structurally determined
[25]. Within the selectivity ¢lter and preceding pore helix,
there is a high degree of sequence similarity between KcsA,
HERG and M-eag. In the upstream turret area, the sequence
diverges among all three channels.
As a ¢rst test of the sensitivity of the pore region to toxin
binding, we replaced the pore in HERG with the correspond-
ing sequences of M-eag (HMH ; Fig. 3). The HMH chimera is
not sensitive to ErgTx. The currents were not modi¢ed in the
presence of toxin. However, as it can be observed in Fig. 3C,
the substitution of the pore region (M-eag into Herg) abol-
ishes the recti¢cation property of the channel. Fig. 3C does
not show the e¡ect of the toxin, but rather compares the
behavior of the native M-eag (circles) with that of the chimera
(triangles). This observation suggests that the amino acid se-
quence of the S5^P loop segment of HERG channel, although
similar to that of M-eag in size, contains information or spa-
tial folding that makes it di¡erent. ErgTx senses the di¡erence
between them.
To con¢rm that pore sequences of HERG were important
Fig. 2. Scheme showing the chimeric constructions and point mutants of HERG channels. Upper line shows the amino acid sequence of
HERG channel from residue G572 to K638. The stars on top of amino acids indicate point mutations: D580A, D591A, I593R, N593Q, S620T
and S631V. The subsequent lines show: (i) a schematic representation of HERG channel sequence from the S5 to S6 transmembrane regions
(shadowed boxes), where the arrows show the position of the amino acids from G572 to K638; (ii) the equivalent scheme for the M-eag chan-
nel (empty boxes); (iii) the chimeric M-eag^HERG^M-eag channel, where the sequence from V612 to L650 is from HERG; (iv) the M382H
chimeric construction in which the N-terminal is from M-eag up to T556 and the remaining sequence is from HERG and (v) the last chimeric
is HERG sequence up to C566 and after K638, whereas the internal segment is from M-eag I396^K577.
Fig. 3. E¡ect of ErgTx on HMH chimera. A: Left shows outward currents, under voltage clamp conditions for control recordings (similar to
M-eag channel alone), and right is in the presence of 200 nM ErgTx. B: The scheme of the chimera (N-terminal and C-terminal of HERG in
bold, middle section is from M-eag channels). C: Current versus voltage relationship of the outward currents of A compared with M-eag chan-
nels (circles), for n = 5.
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in toxin binding, we studied the chimera MHM, an M-eag
channel in which the P-region beginning between the turret
and the pore helix, and extending half-way through S6, has
been replaced with corresponding HERG sequences (see Sec-
tion 2 and [24]). Despite possessing much of the HERG pore,
MHM exhibited a drastically reduced sensitivity to ErgTx
(Fig. 4A^C). Currents were reduced by only 15%, even at
high toxin concentrations (100 nM). This chimera exhibits
the rapid activation characteristic of M-eag and the rapid
inactivation characteristic of HERG, resulting in a partially
inactivating, large outward current intermediate between the
two parental phenotypes (see also [24]). The intact inactiva-
tion indicates that the external mouth of the pore retains its
normal function and suggests that the relative lack of toxin
binding is not due to a general disruption of structure in that
region.
Because MHM does not contain the entire HERG pore
sequence, including the ‘turret’, we tested the sensitivity of
the chimera M382H, which contains a pore composed entirely
of HERG sequence. As shown in Fig. 4, M382H is clearly
inhibited by ErgTx (Fig. 4D^F). This chimera exhibits the
pronounced inward recti¢cation characteristic of the wild-
type HERG channel. The block is about 80%, using 100
Fig. 4. E¡ect of ErgTx on MHM and M382H chimeras. A^C are from MHM, whose caricature is depicted in B (N-terminal of HERG and C-
terminal from M-eag in bold), whereas D^F are from the M382H chimera, scheme shown in E. Panel A shows the outward currents elicited
according to the protocol of Fig. 1, for control (upper recordings), after application of 100 nM ErgTx (middle) and after washing (lower pan-
el). Panel C shows the current versus voltage curve of the results in A, where the squares represent the control, triangles the toxin e¡ect and
the open circles the washing condition (n = 3, P6 0.005). D: The same situation as A, for the M382H, and F is the corresponding current ver-
sus voltage curve, where the squares represent the recording of the control, triangles the toxin e¡ect and the open circles the recovery (n = 4,
P6 0.02).
Fig. 5. Percent of blockage for the site-directed mutants. This
graphic shows the percent of blockage due to the application of 100
nM ErgTx for the point mutants, shown on the left: D580A,
D591A, N598Q, S620T, S631V and wild-type (WT). Error bars indi-
cate mean ( þ S.E.M., n = 3).
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nM ErgTx, and it is reversible by washing. These observations
strongly support a role for the HERG pore region in ErgTx
block, especially in the highly divergent turret region that
distinguishes HERG from M-eag, M-elk and other K chan-
nels. Moreover, they exclude a primary role for residues in the
HERG S3^S4 region in toxin binding.
Finally, we tested six point mutations in this region in an
attempt to identify particular amino acids that specify the
binding preference of ErgTx for HERG channel (see Fig. 5).
Among the mutants tested, only N598Q showed a small re-
duction in inhibition by the toxin, exhibiting 60% compared
with 80% inhibition of wild-type channels. However, this 25%
reduction of inhibition should be taken only as an indication
for the need of additional point mutation studies in this seg-
ment of the channel. I593R did not express. Surprisingly,
mutations that disrupt C-type inactivation (and presumably
the conformation of the outer pore region), S620T and S631V,
had little e¡ect on toxin inhibition of the current. Considering
that agitoxin and charybdotoxin binding are disrupted by
Shaker mutations equivalent to S631V, our ¢ndings suggest
that their mechanisms of binding are likely to di¡er from that
of ErgTx in HERG. Perhaps this should not be surprising, as
the amino acid sequence of ErgTx is quite di¡erent from the
other known Kv speci¢c toxins (42 amino acids with four
disul¢de bridges; see [23]). More surprising may be the insen-
sitivity of ERG channels to other K channel toxins from
scorpions, despite homology in the binding regions. One can
speculate that structural di¡erences, most notably the long
sequence predicted to give rise to an unusually large turret
(see review by Tseng [26]), present steric hindrance to an oth-
erwise conserved binding site.
In conclusion, our results support the idea that ErgTx is
speci¢c for HERG channel and does not recognize other,
closely related channels. It is a legitimate blocker of HERG,
able to recognize the amino acid sequence between the S5^P
loop region. The speci¢c binding sites are either di¡erent from
the location where other scorpion toxins bind to the Kv chan-
nels, or the structure of the S5^P loop region of HERG chan-
nel is di¡erent from that of the voltage-dependent K chan-
nels. More mutagenesis studies will be required to pinpoint
the residues specifying ErgTx block.
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